Vivanza Biosciences Limited

₹1.48As of Sun 8 Nov 2026, 12:00 UTC
BSE:530057Healthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR (17.51%)
Div yield —
ROE 0.60%
Pharmaceutical Preparations
Beta (5Y) 0.35
PE TTM 213.3
TSR TTM (24.49%)
Mkt cap ₹59.20M
ROIC 0.37%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹1.77
19.53%
(4.19%)
Hold 11|6|5|8|1
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.02
0.02
0.02
0.02
1.66%
2.45%
8.70%
5.14%
Revenue₹M
4.854
4.896
5.158
5.278
2.50%
2.70%
9.66%
7.82%
Peers (US$0.630M)
Cap (US$)
PE
0.673M
7.964x
Capital
TTM
5Y
10Y
Leveragex
4.257
0.468
0.497
EBIT/Intx
1.117
0.526
0.480
Own earn%
(14.52)
133.42
104.82
Sh yield%
40.33
39.56
37.05
Owners
Insiders/Inst%
11.81
86.21
Short interest%
4.20
SBC / revenue%
5.40
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
30–37
$1 testx
0.0
Incr. ROIC%
5